Siddharth Singh

Title(s)Assistant Professor Of Clinical, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    All India Institute of Medical Sciences, New DelhiMD2006Medicine
    UCLA and VA Greater Los Angeles Healthcare SystemPostdoctoral Scholarship2008Membrane Biology
    University of Iowa Hospitals and ClinicsInternship2009Internal Medicine
    University of Iowa Hospitals and ClinicsResidency2011Internal Medicine
    Mayo Clinic, RochesterFellowship2014Gastroenterology & Hepatology
    Mayo Clinic, RochesterAdvanced Fellowship2015Inflammatory Bowel Diseases
    Mayo Clinic, RochesterMaster's Degree2015Clinical and Translational Science

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2021 12; 6(12):1002-1014. Singh S, Murad MH, Fumery M, Sedano R, Jairath V, Panaccione R, Sandborn WJ, Ma C. PMID: 34688373; PMCID: PMC8933137.
      View in: PubMed   Mentions:
    2. Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-α Antagonists in Patients with Inflammatory Bowel Diseases. Dig Dis Sci. 2021 Jun 03. Singh S, Heien HC, Sangaralingham L, Shah ND, Sandborn WJ. PMID: 34085174; PMCID: PMC8933138.
      View in: PubMed   Mentions:    Fields:    
    3. Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2022 02; 20(2):e74-e88. Singh S, Heien HC, Herrin J, Dulai PS, Sangaralingham L, Shah ND, Sandborn WJ. PMID: 33640480; PMCID: PMC8384969.
      View in: PubMed   Mentions: 1     Fields:    
    4. Management of Inflammatory Bowel Diseases: Clinical Perspectives. Clin Gastroenterol Hepatol. 2020 05; 18(6):1249-1251. Singh S, Peyrin-Biroulet L, Ananthakrishnan A. PMID: 32057974.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis. Clin Gastroenterol Hepatol. 2020 09; 18(10):2179-2191.e6. Singh S, Murad MH, Fumery M, Dulai PS, Sandborn WJ. PMID: 31945470; PMCID: PMC8022894.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    6. Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or Obstetric. Clin Gastroenterol Hepatol. 2020 05; 18(6):1367-1380. Singh S, Picardo S, Seow CH. PMID: 31712084; PMCID: PMC7183892.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    7. Network meta-analysis to inform positioning of biologics in patients with Crohn's disease: Promise and perils. Best Pract Res Clin Gastroenterol. 2019 Feb - Apr; 38-39:101614. Singh S. PMID: 31327401.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Comparative Efficacy and Speed of Onset of Action of Infliximab vs Golimumab in Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 02; 18(2):424-431.e7. Singh S, Proudfoot JA, Dulai PS, Xu R, Feagan BG, Sandborn WJ, Jairath V. PMID: 31108227; PMCID: PMC6858937.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2020 01; 18(1):69-81.e3. Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ. PMID: 30876964; PMCID: PMC8011651.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    10. Evolution of Clinical Trials in Inflammatory Bowel Diseases. Curr Gastroenterol Rep. 2018 Aug 04; 20(9):41. Singh S. PMID: 30078058.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Management of Crohn's Disease After Surgical Resection. Gastroenterol Clin North Am. 2017 09; 46(3):563-575. Singh S, Nguyen GC. PMID: 28838415.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    12. Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):27-38.e4. Singh S, Facciorusso A, Loomba R, Falck-Ytter YT. PMID: 28479504; PMCID: PMC5671365.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    13. Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study. Clin Gastroenterol Hepatol. 2017 Aug; 15(8):1218-1225.e7. Singh S, Andersen NN, Andersson M, Loftus EV, Jess T. PMID: 27913244; PMCID: PMC5447492.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    14. Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2016 08; 14(8):1120-1129.e6. Singh S, Heien HC, Sangaralingham LR, Schilz SR, Kappelman MD, Shah ND, Loftus EV. PMID: 27058635; PMCID: PMC4955682.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    15. Letter: faecal diversion for severe perianal Crohn's disease - practical issues. Authors' reply. Aliment Pharmacol Ther. 2015 Nov; 42(10):1237. Singh S, Ding NS, investigators. PMID: 26449866.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. Gastroenterology. 2015 Oct; 149(4):958-70.e12. Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH. PMID: 26091937.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    Siddharth's Networks
    Concepts (81)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California